Author:
Akbik F,Hirsch J A,Chandra R V,Frei D,Patel A B,Rabinov J D,Rost N,Schwamm L H,Leslie-Mazwi T M
Abstract
Acute ischemic stroke remains a major public health concern, with low national treatment rates for the condition, demonstrating a disconnection between the evidence of treatment benefit and delivery of this treatment. Intravenous thrombolysis and endovascular thrombectomy are both strongly evidence supported and exquisitely time sensitive therapies. The mismatch between the distribution and incidence of stroke presentations and the availability of specialist care significantly affects access to care. Telestroke, the use of telemedicine for stroke, aims to surmount this hurdle by distributing stroke expertise more effectively, through video consultation with and examination of patients in locations removed from specialist care. This is the first of a detailed two part review, and explores the growth and current practice of telestroke, including the specific role it plays in the assessment and management of patients after emergent large vessel occlusion.
Subject
Neurology (clinical),General Medicine,Surgery
Reference82 articles.
1. Heart disease and stroke statistics—2012 update: a report from the American Heart Association;Roger;Circulation,2012
2. Heart disease and stroke statistics—2013 update: a report from the American Heart Association;Go;Circulation,2013
3. Tissue plasminogen activator for acute ischemic stroke;The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group;N Engl J Med,1995
4. Urgent therapy for stroke. Part I. Pilot study of tissue plasminogen activator administered within 90 minutes;Brott;Stroke,1992
5. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials;Lees;Lancet,2010
Cited by
43 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献